Inhibitory effect of loganin on locomotor activity in normal mice. 5–240 min after administration of loganin (5, 20, 50 mg/kg, i.g.) or estazolam (0.15 mg/kg, i.g.), spontaneous locomotor activity was monitored. Data are presented as means ± SEM (n = 12). +P < 0.05, loganin 5 mg/kg, vs. the control group; XP < 0.05, loganin 20 mg/kg, vs. the control group; ∗P < 0.05, ∗∗P < 0.01, loganin 50 mg/kg vs. the control group; #P < 0.05, ##P < 0.01, estazolam 0.15 mg/kg, vs. the control group (one-way ANOVA followed by Student-Newman-Keuls test).
Description
Dose-response analysis of loganin's hypnotic effects in the pentobarbital sleep model reveals concentration-dependent changes in sleep parameters.
FIGURE 3
ChartSource Paper
Loganin Exerts Sedative and Hypnotic Effects via Modulation of the Serotonergic System and GABAergic Neurons.Cite This Figure
 > Source: Rui Shi et al. "Loganin Exerts Sedative and Hypnotic Effects via Modulation of the Serotonergic ." *Frontiers in pharmacology*, 2019. PMID: [31068813](https://pubmed.ncbi.nlm.nih.gov/31068813/)
<figure> <img src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491506/bin/fphar-10-00409-g003.jpg" alt="Dose-response analysis of loganin's hypnotic effects in the pentobarbital sleep model reveals concentration-dependent changes in sleep parameters." /> <figcaption>FIGURE 3. Dose-response analysis of loganin's hypnotic effects in the pentobarbital sleep model reveals concentration-dependent changes in sleep parameters.<br> Source: Rui Shi et al. "Loganin Exerts Sedative and Hypnotic Effects via Modulation of the Serotonergic ." <em>Frontiers in pharmacology</em>, 2019. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/31068813/">31068813</a></figcaption> </figure>